Nwb* is the comparison and it has 7x the SS. It is at $1.50. Was 10 cent to 40 cent during phase 1 to phase 2. Phase 3 got it over $1. Went from $60M market value to $1 billion this year.
CTYX already talking phase 3. With FDA loosen some requirements. But for now phase 1 and comparing to nwb* is a good start to see where this is going with a much smaller Share structure
News 
Market Data 
Discover 
AI
